JP2020182486A5 - - Google Patents

Download PDF

Info

Publication number
JP2020182486A5
JP2020182486A5 JP2020123157A JP2020123157A JP2020182486A5 JP 2020182486 A5 JP2020182486 A5 JP 2020182486A5 JP 2020123157 A JP2020123157 A JP 2020123157A JP 2020123157 A JP2020123157 A JP 2020123157A JP 2020182486 A5 JP2020182486 A5 JP 2020182486A5
Authority
JP
Japan
Prior art keywords
antigen
conjugation
subject
cell
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020123157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020182486A (ja
JP7079819B2 (ja
Filing date
Publication date
Priority claimed from GB201415247A external-priority patent/GB201415247D0/en
Priority claimed from GB201420773A external-priority patent/GB201420773D0/en
Application filed filed Critical
Publication of JP2020182486A publication Critical patent/JP2020182486A/ja
Publication of JP2020182486A5 publication Critical patent/JP2020182486A5/ja
Application granted granted Critical
Publication of JP7079819B2 publication Critical patent/JP7079819B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020123157A 2014-08-28 2020-07-17 化合物および方法 Active JP7079819B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB201415247A GB201415247D0 (en) 2014-08-28 2014-08-28 Compound and method
GB1415247.4 2014-08-28
GB1420773.2 2014-11-21
GB201420773A GB201420773D0 (en) 2014-11-21 2014-11-21 Compound and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017511702A Division JP2017526371A (ja) 2014-08-28 2015-08-28 化合物および方法

Publications (3)

Publication Number Publication Date
JP2020182486A JP2020182486A (ja) 2020-11-12
JP2020182486A5 true JP2020182486A5 (enExample) 2021-04-15
JP7079819B2 JP7079819B2 (ja) 2022-06-02

Family

ID=54065872

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017511702A Pending JP2017526371A (ja) 2014-08-28 2015-08-28 化合物および方法
JP2020123157A Active JP7079819B2 (ja) 2014-08-28 2020-07-17 化合物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017511702A Pending JP2017526371A (ja) 2014-08-28 2015-08-28 化合物および方法

Country Status (10)

Country Link
US (1) US10537639B2 (enExample)
EP (1) EP3185901B1 (enExample)
JP (2) JP2017526371A (enExample)
KR (1) KR102678732B1 (enExample)
CN (1) CN108136016A (enExample)
AU (1) AU2015308345B9 (enExample)
BR (1) BR112017003486A2 (enExample)
CA (1) CA2959207A1 (enExample)
NZ (1) NZ729408A (enExample)
WO (1) WO2016030529A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912607B (zh) * 2018-12-11 2021-01-22 南华大学 一类卟啉-白杨素复合物及其抗肿瘤活性
ES3039706T3 (en) 2019-02-19 2025-10-24 Otsuka Denshi Kk Method for determining condition parameters for photodynamic therapy and photodynamic therapy apparatus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
CN100558903C (zh) 2000-11-29 2009-11-11 Pci生物技术联合股份有限公司 将分子输递进胞质溶胶的光化学内化法
MXPA03005373A (es) 2000-12-13 2004-03-26 Inmunex Corp Metodo para generar lineas celulares dentriticas inmortales.
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
JP5285855B2 (ja) * 2003-11-12 2013-09-11 アメリカ合衆国 膵癌を処置および予防するためのカスタムベクター
WO2005100547A1 (ja) * 2004-04-06 2005-10-27 Techno Network Shikoku Co., Ltd. 抗原パルスして得られた樹状細胞
WO2005097976A1 (ja) * 2004-04-06 2005-10-20 Ehime University 抗原パルスして得られた樹状細胞
CA2728423A1 (en) * 2008-06-06 2009-12-10 Baylor Research Institute Respiratory syncytial virus renders dendritic cells tolerogenic
WO2011011797A2 (en) 2009-07-24 2011-01-27 The Board Of Trustees Of The Leland Stanford Junior University Cytokine compositions and methods of use thereof
GB201208548D0 (en) * 2012-05-15 2012-06-27 Pci Biotech As Compound and method
US20160040128A1 (en) * 2013-03-15 2016-02-11 Pci Biotech As Method
AU2014314149B2 (en) * 2013-08-28 2019-12-19 Pci Biotech As Compound and method for vaccination and immunisation
WO2015028575A1 (en) * 2013-08-28 2015-03-05 Pci Biotech As Immunisation method by photochemical internalisation
EP3129045B1 (en) * 2014-04-11 2022-03-02 PCI Biotech AS Method of treating melanoma

Similar Documents

Publication Publication Date Title
Kreutz et al. Targeting dendritic cells—why bother?
ES2350043T3 (es) Composiciones para producir, incrementar y mantener las respuestas inmunes contra epítopos restringidos de mhc de clase i, con fines profilácticos o terapéuticos.
US20250009888A1 (en) Compounds including a mutant kras sequence and a lipid and uses thereof
CN101443005A (zh) 免疫反应调节制剂和方法
JP2019123751A (ja) 免疫賦活活性を有するオリゴヌクレオチド含有複合体及びその用途
CA3016457A1 (en) Sting activating nanovaccine for immunotherapy
TW200307557A (en) Stabilized synthetic immunogen delivery systems
RU2014150569A (ru) Конъюгат фотосенсибилизатора и хитозана и его применение
US8834899B2 (en) Photodynamic therapy-generated mesothelioma vaccine
Chen et al. Maximizing TLR9 activation in cancer immunotherapy with dual-adjuvanted spherical nucleic acids
TWI861015B (zh) 包含抗原肽-佐劑核苷酸結合物之免疫誘導劑及包含其之醫藥組成物
JP2020182486A5 (enExample)
Dewangan et al. Nanovaccine for transdermal delivery system
CN103961697A (zh) 粘膜给予用疫苗组合物
Lee et al. Biodegradable cationic polycarbonates as vaccine adjuvants
JP2006502228A5 (enExample)
Ou et al. Transcutaneous Immunization of 1D Rod-Like Tobacco-Mosaic-Virus-Based Peptide Vaccine via Tip-Loaded Dissolving Microneedles
US11464798B2 (en) Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same
BRPI0618847A2 (pt) novos adjuvantes com base em conjugados de bisaciloxipropilcisteìna e derivados e seus usos em composições farmacêuticas
JPH07504662A (ja) 免疫無防備状態の宿主における治療用途のための免疫促進剤
EP1237573B1 (fr) Utilisation de proteines immunogenes immunosuppressives ou angiogeniques rendues inactives pour la production d'lga secretoires
RU2404794C2 (ru) Вагинальные суппозитории для лечения рака шейки матки
JPWO2020217226A5 (enExample)
RU2379055C1 (ru) Способ лечения онкологических заболеваний
ES2280948T3 (es) Composiciones de vacunas basadas en gangliosidos para administracion por via subcutanea.